BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38001958)

  • 1. Exogenous Volatile Organic Compound (EVOC
    Ferrandino G; Ricciardi F; Murgia A; Banda I; Manhota M; Ahmed Y; Sweeney K; Nicholson-Scott L; McConville L; Gandelman O; Allsworth M; Boyle B; Smolinska A; Ginesta Frings CA; Contreras J; Asenjo-Lobos C; Barrientos V; Clavo N; Novoa A; Riviotta A; Jerez M; Méndez L
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001958
    [No Abstract]   [Full Text] [Related]  

  • 2. Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples.
    Fernández Del Río R; O'Hara ME; Holt A; Pemberton P; Shah T; Whitehouse T; Mayhew CA
    EBioMedicine; 2015 Sep; 2(9):1243-50. PubMed ID: 26501124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.
    Ferrandino G; Orf I; Smith R; Calcagno M; Thind AK; Debiram-Beecham I; Williams M; Gandelman O; de Saedeleer A; Kibble G; Lydon AM; Mayhew CA; Allsworth M; Boyle B; van der Schee MP; Allison M; Hoare M; Snowdon VK
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00239. PubMed ID: 33094960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
    Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
    JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breath Biopsy
    Ferrandino G; De Palo G; Murgia A; Birch O; Tawfike A; Smith R; Debiram-Beecham I; Gandelman O; Kibble G; Lydon AM; Groves A; Smolinska A; Allsworth M; Boyle B; van der Schee MP; Allison M; Fitzgerald RC; Hoare M; Snowdon VK
    J Clin Transl Hepatol; 2023 Jun; 11(3):638-648. PubMed ID: 36969895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Breath Limonene Sensing at High Selectivity.
    Weber IC; Oosthuizen DN; Mohammad RW; Mayhew CA; Pratsinis SE; Güntner AT
    ACS Sens; 2023 Jul; 8(7):2618-2626. PubMed ID: 37377394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot study.
    Thomas JN; Roopkumar J; Patel T
    PLoS One; 2021; 16(11):e0260098. PubMed ID: 34847181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the
    Konstantinou D; Margariti E; Hadziyannis E; Pectasides D; Papatheodoridis GV
    Ann Gastroenterol; 2014; 27(1):53-59. PubMed ID: 24714782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breath biomarkers of liver cirrhosis.
    Dadamio J; Van den Velde S; Laleman W; Van Hee P; Coucke W; Nevens F; Quirynen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():17-22. PubMed ID: 22921634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases.
    Murgia A; Ahmed Y; Sweeney K; Nicholson-Scott L; Arthur K; Allsworth M; Boyle B; Gandelman O; Smolinska A; Ferrandino G
    Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
    Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis.
    Koo S; Thomas HR; Daniels SD; Lynch RC; Fortier SM; Shea MM; Rearden P; Comolli JC; Baden LR; Marty FM
    Clin Infect Dis; 2014 Dec; 59(12):1733-40. PubMed ID: 25342502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel breath biomarkers identification for early detection of hepatocellular carcinoma and cirrhosis using ML tools and GCMS.
    Ain Nazir NU; Shaukat MH; Luo R; Abbas SR
    PLoS One; 2023; 18(11):e0287465. PubMed ID: 37967076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cr
    Bhateja Y; Ghosh R; Sponer J; Majumdar S; Cassone G
    Phys Chem Chem Phys; 2022 Sep; 24(35):21372-21380. PubMed ID: 36043859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limonene in exhaled breath is elevated in hepatic encephalopathy.
    O'Hara ME; Fernández Del Río R; Holt A; Pemberton P; Shah T; Whitehouse T; Mayhew CA
    J Breath Res; 2016 Nov; 10(4):046010. PubMed ID: 27869108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
    Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
    Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study for the prediction of liver function related scores using breath biomarkers and machine learning.
    Patnaik RK; Lin YC; Agarwal A; Ho MC; Yeh JA
    Sci Rep; 2022 Feb; 12(1):2032. PubMed ID: 35132067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection.
    Giannini E; Fasoli A; Chiarbonello B; Malfatti F; Romagnoli P; Botta F; Testa E; Polegato S; Fumagalli A; Testa R
    Aliment Pharmacol Ther; 2002 Apr; 16(4):717-25. PubMed ID: 11929389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.